Impurities & Reference Standards Supplier in United States
Pharmacopoeial and non-pharmacopoeial impurities, metabolites, nitrosamines and working standards with characterisation data for QC and regulatory work. Pharma QC labs in United States use our impurity and reference standards for method validation, ANDA and DMF work.
Impurities & Reference Standards for United States
This division supplies the reference materials that analytical teams need to identify and quantify impurities in APIs and finished products. It covers pharmacopoeial and process impurities, degradation products, metabolites, stable-isotope labelled compounds, nitrosamine drug-substance-related impurities (NDSRIs), genotoxic impurity standards and secondary working standards.
Standards are typically supplied in milligram quantities with a characterisation package that can include HPLC purity, 1H-NMR, mass spectrometry, IR and, where relevant, TGA or water content. Custom synthesis can be arranged for impurities that are not commercially listed, subject to feasibility. A COA and SDS accompany every shipment, and many items travel as non-hazardous small packs by courier.
Pharmaceutical QC and analytical development laboratories, regulatory affairs teams preparing ANDA, DMF or MAA submissions, CROs running method validation and forced degradation studies, and nitrosamine risk-assessment projects are the main users. Clear structural data and batch traceability matter more than volume here, so each standard is identified by chemical name, CAS number where assigned and molecular formula. Storage conditions and retest dates are stated on the label and COA so that labs can manage standards within their own qualification systems.
Grades available
Compliance in United States
Regulator: FDA (CDER)
Chemical substances imported into the US must comply with the Toxic Substances Control Act, and the importer files a TSCA positive or negative certification at entry. Substances must be on the TSCA Inventory or exempt. APIs for human drugs are FDA-regulated, typically supported by a Drug Master File and cGMP manufacturing, and are subject to FDA entry review (FSVP applies to food, not chemicals). List I and List II chemicals require DEA import registration and declarations, and ocean shipments need an ISF 10+2 filing with CBP before loading.
Shipping lanes
- New York / New Jersey
- Houston
- Savannah
- New York JFK (JFK)
- Chicago O'Hare (ORD)
Typical buyers: Pharma QC and analytical development labs, Regulatory affairs teams, Contract research organisations, Generic drug developers, Nitrosamine risk-assessment projects, Academic pharmaceutical analysis groups.
Selected Impurities & Reference Standards shipped to United States
FAQs — Impurities & Reference Standards in United States
Do you supply Impurities & Reference Standards to United States?
Yes. We export Impurities & Reference Standards to United States by sea freight to New York / New Jersey or Houston, by air cargo, or by express courier for small R&D packs. Every shipment includes a COA and a GHS SDS.
How long does delivery to United States take?
Typical sea transit from India to United States is 28–40 days and air freight 3–6 days, plus production/packing lead time and customs clearance.
What characterisation data comes with an impurity standard?
A typical package includes HPLC purity, 1H-NMR and mass spectrum, with IR, TGA or water content where relevant. The exact data set is stated per product before ordering.
Can you synthesise an impurity that is not listed?
Custom synthesis can be arranged for many unlisted impurities and metabolites, subject to technical feasibility. Lead time and price are quoted after structure review.
Do you supply nitrosamine impurity standards?
Yes, a range of small-molecule nitrosamines and NDSRIs is available or can be synthesised to support risk assessments and confirmatory testing.
Other divisions for United States
Impurities & Reference Standards in nearby markets
Impurities & Reference Standards quote — United States
We reply within one business day with price, pack options, lead time and documentation.